Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. (Record no. 27854113)
[ view plain ]
| 000 -LEADER | |
|---|---|
| fixed length control field | 02059 a2200661 4500 |
| 005 - DATE AND TIME OF LATEST TRANSACTION | |
| control field | 20250517190511.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION | |
| fixed length control field | 201806s 0 0 eng d |
| 022 ## - INTERNATIONAL STANDARD SERIAL NUMBER | |
| International Standard Serial Number | 1437-7772 |
| 024 7# - OTHER STANDARD IDENTIFIER | |
| Standard number or code | 10.1007/s10147-017-1220-0 |
| Source of number or code | doi |
| 040 ## - CATALOGING SOURCE | |
| Original cataloging agency | NLM |
| Language of cataloging | eng |
| Transcribing agency | NLM |
| 100 1# - MAIN ENTRY--PERSONAL NAME | |
| Personal name | Kwakman, Johannes J M |
| 264 #0 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE | |
| Date of production, publication, distribution, manufacture, or copyright notice | 20180619 |
| 245 00 - TITLE STATEMENT | |
| Title | Feasibility and effectiveness of trifluridine/tipiracil in metastatic colorectal cancer: real-life data from The Netherlands. |
| Medium | [electronic resource] |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. | |
| Name of publisher, distributor, etc. | International journal of clinical oncology |
| Date of publication, distribution, etc. | Jun 2018 |
| 300 ## - PHYSICAL DESCRIPTION | |
| Extent | 482-489 p. |
| Other physical details | digital |
| 500 ## - GENERAL NOTE | |
| General note | Publication Type: Journal Article; Multicenter Study |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Adult |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Aged, 80 and over |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Antineoplastic Combined Chemotherapy Protocols |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Colorectal Neoplasms |
| General subdivision | drug therapy |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Disease-Free Survival |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Drug Combinations |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Female |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Humans |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Leukopenia |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Male |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Middle Aged |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Netherlands |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Neutropenia |
| General subdivision | chemically induced |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Prognosis |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Pyrrolidines |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Thymine |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Treatment Outcome |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Trifluridine |
| General subdivision | adverse effects |
| 650 04 - SUBJECT ADDED ENTRY--TOPICAL TERM | |
| Topical term or geographic name entry element | Uracil |
| General subdivision | adverse effects |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vink, G |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vestjens, J H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Beerepoot, L V |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | de Groot, J W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Jansen, R L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Opdam, F L |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Boot, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Creemers, G J |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Rooijen, J M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Los, M |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Vulink, A J E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Schut, H |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | van Meerten, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Baars, A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Hamberg, P |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Kapiteijn, E |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Sommeijer, D W |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Punt, C J A |
| 700 1# - ADDED ENTRY--PERSONAL NAME | |
| Personal name | Koopman, M |
| 773 0# - HOST ITEM ENTRY | |
| Title | International journal of clinical oncology |
| Related parts | vol. 23 |
| -- | no. 3 |
| -- | p. 482-489 |
| 856 40 - ELECTRONIC LOCATION AND ACCESS | |
| Uniform Resource Identifier | <a href="https://doi.org/10.1007/s10147-017-1220-0">https://doi.org/10.1007/s10147-017-1220-0</a> |
| Public note | Available from publisher's website |
No items available.